New partnership between the CIS - [4 - (3 - hexahydrocyclopenta [c] pyrrole - il - 2 (1H) propoxy]} benzamiday an antagonist of NMDA Receptors, and Pharmaceutical compositions containing it
Association between the CIS - [4 - (3 - hexahydrocyclopenta [c] pyrrole - 2 (1H) - yl] benzamide propoxy} of formula (i) or its Salts addition to a pharmaceutically acceptable acid or a base, and an antagonist of the NMDA glutamatergic receptors.Asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1H) -il]propoxi}benzamida de fórmula (I) o una de sus sales de adición a un ácido o a una base farmacéuticamente aceptable, y un antagonista de los receptores glutamatérgicos NMDA.